PeterLabs Holdings Bhd (0171) - Total Liabilities

Latest as of September 2025: RM21.70 Million MYR ≈ $5.45 Million USD

Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has total liabilities worth RM21.70 Million MYR (≈ $5.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how liquid is PeterLabs Holdings Bhd's working capital to evaluate short-term liquidity relative to the company's equity base.

PeterLabs Holdings Bhd - Total Liabilities Trend (2015–2024)

This chart illustrates how PeterLabs Holdings Bhd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PeterLabs Holdings Bhd assets under control.

PeterLabs Holdings Bhd Competitors by Total Liabilities

The table below lists competitors of PeterLabs Holdings Bhd ranked by their total liabilities.

Company Country Total Liabilities
Grand Central Enterprises Bhd
KLSE:5592
Malaysia RM7.50 Million
Mannatech Incorporated
NASDAQ:MTEX
USA $26.97 Million
SPAR Group Inc
NASDAQ:SGRP
USA $45.08 Million
Precipitate Gold Corp
V:PRG
Canada CA$338.68K
Niocan Inc
V:NIO
Canada CA$216.05K
Swvl Holdings Corp
NASDAQ:SWVL
USA $17.53 Million
Telefield Inc
KQ:091440
Korea ₩92.13 Billion
Domo Activos Socimi SA
MC:DOMO
Spain €215.90K

Liability Composition Analysis (2015–2024)

This chart breaks down PeterLabs Holdings Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 0171 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.93 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PeterLabs Holdings Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PeterLabs Holdings Bhd (2015–2024)

The table below shows the annual total liabilities of PeterLabs Holdings Bhd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 RM34.09 Million
≈ $8.56 Million
-8.23%
2023-12-31 RM37.15 Million
≈ $9.33 Million
+16.63%
2022-12-31 RM31.85 Million
≈ $8.00 Million
-18.63%
2021-12-31 RM39.15 Million
≈ $9.83 Million
+159.78%
2020-12-31 RM15.07 Million
≈ $3.78 Million
-25.62%
2019-12-31 RM20.26 Million
≈ $5.09 Million
-17.46%
2018-12-31 RM24.55 Million
≈ $6.16 Million
+5.89%
2017-12-31 RM23.18 Million
≈ $5.82 Million
+3.87%
2016-12-31 RM22.32 Million
≈ $5.60 Million
+93.89%
2015-12-31 RM11.51 Million
≈ $2.89 Million
--

About PeterLabs Holdings Bhd

KLSE:0171 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$15.55 Million
RM61.92 Million MYR
Market Cap Rank
#25972 Global
#749 in Malaysia
Share Price
RM0.23
Change (1 day)
+2.27%
52-Week Range
RM0.20 - RM0.28
All Time High
RM0.45
About

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more